Pioglitazone, a PPAR-γ ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-κB-cytokine cascade

Redox Report

Volumn 7, Issue 5, 2002, Pages 283-289

  Takagi, Tomohisa ^a   Naito, Yuji ^a   Tomatsuri, Naoya ^a   Handa, Osamu ^a   Ichikawa, Hiroshi ^a   Yoshida, Norimasa ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; LIPID; LIPID PEROXIDE; MESSENGER RNA; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIOGLITAZONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; DRUG TARGETING; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC CODE; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; INTESTINE MUCOSA; LIPID PEROXIDATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; ORGAN SIZE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WEIGHT REDUCTION;

ANIMALS; ANTICOAGULANTS; BODY WEIGHT; COLITIS; COLON; DEXTRAN SULFATE; DNA; FEMALE; HYPOGLYCEMIC AGENTS; INFLAMMATION; LIGANDS; MICE; MICE, INBRED BALB C; NF-KAPPA B; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN BINDING; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THIAZOLES; THIAZOLIDINEDIONES; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0036924470     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1179/135100002125000802     Document Type: Article

References (38)

1. Levine AD, Fiocchi C. Immunology of inflammatory bowel disease. Curr Opin Gastroenterol 2000; 16: 306-309.
2. Barnes PJ, Karin M. Nuclear factor-κB: a pivotal transcriptional factor in chronic inflammatory disease. N Engl J Med 1997; 336: 1066-1071.
3. Neurath MF, Pettersson S, Meyer BKH, Strober W. Local administration of antisense phosphorothionate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med 1996; 2: 998-1004.
4. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694-702.
5. Herfarth H, Brand K, Rath HC, Rogler G, Scholmerich J, Falk W. Nuclear factor-κB activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin. Clin Exp Immunol 2000; 120: 59-65.
6. Lemberger T, Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu Rev Cell Dev Biol 1996; 12: 335-363.
7. Schoonjans K, Martin G, Staels B, Auwerx J. Peroxisome proliferator-activated receptors, orphans with ligands and functions. Curr Opin Lipidol 1997; 8: 159-166.
8. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998; 391: 82-86.
9. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998; 391: 79-82.
10. Su CG, Wen X, Bailey ST et al. A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. J Clin Invest 1999; 104: 383-389.
11. Tanaka T, Kohno H, Yoshitani S et al. Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats. Cancer Res 2001; 61: 2424-2428.
12. Desreumaux P, Dubuquoy L, Nutten S et al. Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimer. A basis for new therapeutic strategies. J Exp Med 2001; 193: 827-838.
13. Naito Y, Takagi T, Ishikawa T et al. The inducible nitric oxide synthase inhibitor ONO-1714 blunts dextran sulfate sodium colitis in mice. Eur J Pharmacol 2001; 412: 91-99.
14. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 1986; 252: G567-G574.
15. Ohkawa H, Ohnishi N, Yagi K. Assay for lipid peroxides for animal tissues by thiobarbituric acid reaction. Anal Biochem 1986; 95: 351-358.
16. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
17. Naito Y, Takagi T, Ishikawa T et al. α-Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice. Antioxidants Redox Signal 2002; 4: 195-206.
18. Breider MA, Eppinger M, Gough A. Intercellular adhesion molecule-1 expression in dextran sodium sulfate-induced colitis in rats. Vet Pathol 1997; 34: 598-604.
19. Natsui M, Kawasaki K, Takizawa H et al. Selective depletion of neutrophils by a monoclonal antibody, RP-3, suppresses dextran sulphate sodium-induced colitis in rats. J Gastroenterol Hepatol 1997; 12: 801-808.
20. Taniguchi T, Tsukada H, Nakamura H et al. Effects of the anti-ICAM-1 monoclonal antibody on dextran sodium sulphate-induced colitis in rats. J Gastroenterol Hepatol 1998; 13: 945-949.
21. Jackson SM, Parhami F, Xi XP et al. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler Thromb Vasc Biol 1999; 19: 2094-2104.
22. Pasceri V, Wu HD, Willerson JT, Yeh ET. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation 2000; 101: 235-238.
23. Yoshikawa T, Miyagawa H, Yoshida N, Sugino S, Kondo M. Increase in lipid peroxidation in rat gastric mucosal lesions induced by water-immersion restraint stress. J Clin Biochem Nutr 1986; 1: 271-277.
24. Yoshikawa T, Yoshida N, Miyagawa H et al. Role of lipid peroxidation in gastric mucosal lesions induced by burn shock in rats. J Clin Biochem Nutr 1987; 2: 163-170.
25. Yoshikawa T, Ueda S, Naito Y et al. Role of oxygen-derived free radicals in gastric mucosal injury induced by ischemia or ischemia-reperfusion in rats. Free Radic Res Commun 1989; 7: 285-291.
26. Iinuma S, Yoshikawa T, Yoshida N, Naito Y, Kondo M. Role of active oxygen species and lipid peroxidation in mepirizole-induced duodenal ulcers in rats. Dig Dis Sci 1998; 43: 1657-1664.
27. Yoshikawa T, Yamaguchi T, Yoshida N et al. Effect of Z-103 on TNB-induced colitis in rats. Digestion 1997; 58: 464-468.
28. Niki E, Komuro E. Inhibition of peroxidation of membranes. Basic Life Sci 1988; 49: 561-566.
29. Niki E, Noguchi N, Gotoh N. Dynamics of lipid peroxidation and its inhibition by antioxidants. Biochem Soc Trans 1993; 21: 313-317.
30. Naito Y, Takagi T, Matsuyama K et al. Effect of a novel water-soluble vitamin E derivative, 2-(α-D-glucopyranoyl)methyl-2,5,7,8-tetramethylchroman-6-ol, on dextran sulfate sodium-induced colitis in mice. J Clin Biochem Nutr 2002; In press.
31. McLaughlan JM, Seth R, Vautier G et al. Interleukin-8 and inducible nitric oxide synthase mRNA levels in inflammatory bowel disease at first presentation. J Pathol 1997; 181: 87-92.
32. Singer I, Kawka DW, Scott S et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996; 111: 871-885.
33. Dijkstra G, Moshage H, van Dullemen HM et al. Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. J Pathol 1998; 186: 416-421.
34. Kimura H, Hokari R, Miura S et al. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut 1998; 42: 180-187.
35. Kojouharoff G, Hans W, Obermeier F et al. Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol 1997; 107: 353-358.
36. Obermeier F, Kojouharoff G, Hans W, Scholmerich J, Gross V, Falk W. Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol 1999; 116: 238-245.
37. Naito Y, Takagi T, Yoshikawa T. NF-κB activation in inflammatory bowel disease. In: Yoshikawa T, Toyokuni S, Yamamoto Y, Naito Y. (eds) Free Radicals in Chemistry, Biology and Medicine. London: OCIA, 2000; 501-513.
38. Murano M, Maemura K, Hirata I et al. Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clin Exp Immunol 2000; 120: 51-58.